Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 6/20 | 0.51 |
| ▸ | CNR2 | P34972 | 11/20 | 0.49 |
| ▸ | CNR1 | P21554 | 8/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.49 |
| ▸ | TRPM8 | Q7Z2W7 | 3/20 | 0.49 |
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.49 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.49 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.49 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 0.49 |
| ▸ | GPR6 | P46095 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31545434 | 1.00 | OPRM1 (0.51) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL25560749 | 1.00 | OPRM1 (0.51) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL25560744 | 0.93 | OPRM1 (0.57) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL23791368 | 0.92 | OPRM1 (0.61) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL21943197 | 0.92 | OPRM1 (0.61) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL18271875 | 0.78 | OPRM1 (0.55) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL22564623 | 0.78 | OPRM1 (0.55) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL23801221 | 0.78 | OPRM1 (0.55) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL16917913 | 0.78 | OPRM1 (0.55) | OPRM1CNR2CNR1TRPV1TRPM8 | |
| SCHEMBL24703763 | 0.76 | CNR2 (0.47) | OPRM1CNR2CNR1TRPV1TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230165807-A1 | COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF | CALIBRATED THERAPEUTICS, LLC | 2023-06-01 | — | — | US | disclosed |
| US-20230165807-A1 | COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF | CALIBRATED THERAPEUTICS, LLC | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165807-A1 | COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF | CNR2, CNR1, FAAH | OPRM1 153/4885CNR2 1/4885CNR1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.